Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization

Biomaterials

Volumn 30, Issue 4, 2009, Pages 508-517

  Yu, Haiying ^a,b   VandeVord, Pamela J ^b   Mao, Li ^b   Matthew, Howard W ^b   Wooley, Paul H ^c   Yang, Shang You ^c,d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Wayne State University   (United States)

^c Orthopaedic Research Institute   (United States)

^d WICHITA STATE UNIVERSITY   (United States)

Author keywords

Bone marrow stromal cells; Bone tissue engineering; Endothelial cells; Neovascularization; Polycaprolactone hydroxyapatite composite

Indexed keywords

APATITE; BIOCOMPATIBILITY; BIOMATERIALS; BIOMECHANICS; BLOOD VESSEL PROSTHESES; BONE; CALCIUM; CARBON FIBER REINFORCED PLASTICS; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELLS; CYTOLOGY; GRAFTING (CHEMICAL); GRAFTS; HYDROXYAPATITE; MECHANICAL PROPERTIES; OSTEOBLASTS; OXYGEN; SELF ASSEMBLY; TISSUE ENGINEERING;

BONE DEFECTS; BONE FORMATIONS; BONE GRAFTS; BONE MARROW STROMAL CELLS; BONE MARROWS; BONE REGENERATIONS; BONE TISSUE ENGINEERING; CALCIUM DEPOSITIONS; CAPROLACTONE; CELL MORPHOLOGIES; CELL POPULATIONS; CELLULAR VIABILITIES; CLINICAL USES; COMPONENT RATIOS; COMPOSITE SCAFFOLDS; ENGINEERED BONE TISSUES; ESSENTIAL NUTRIENTS; HYDROXYAPATITE COMPOSITES; MICROVASCULAR NETWORKS; MONONUCLEAR CELLS; NATURAL BONES; NEOVASCULARIZATION; OSTEOGENESIS; SKELETAL DEVELOPMENTS; VASCULAR NETWORKS; VASCULARIZATION; Y CHROMOSOMES;

ENDOTHELIAL CELLS;

HYDROXYAPATITE; POLYCAPROLACTONE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BONE DEVELOPMENT; BONE MARROW; BONE REGENERATION; CELL POPULATION; CELL STRUCTURE; CELL VIABILITY; COMPOSITE MATERIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; MALE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING; VASCULARIZATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE REGENERATION; BONE TRANSPLANTATION; CELLS, CULTURED; DURAPATITE; ENDOTHELIAL CELLS; HUMANS; IMPLANTS, EXPERIMENTAL; MALE; MICROSCOPY, ELECTRON, SCANNING; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; POLYESTERS; PROSTHESIS IMPLANTATION; RATS; RATS, INBRED LEW; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

RATTUS;

EID: 56749175049     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.09.047     Document Type: Article

References (28)

1. Jain R.K. Molecular regulation of vessel maturation. Nat Med 9 (2003) 685-693
2. Carano R.A.D., and Filvaroff E.H. Angiogenesis and bone repair. Drug Discov Today 8 21 (2003) 980-989
3. Aronson J. Temporal and spatial increases in blood flow during distraction osteogenesis. Clin Orthop Relat Res 301 (1994) 124-131
4. Mooney D.J., and Mikos A.G. Growing new organs. Sci Am 280 (1999) 60-65
5. Masuda H., and Asahara T. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 58 2 (2003) 390-398
6. Rizzi S.C., Heath D.J., Coombes A.G.A., Bock N., Textor M., and Downes S. Biodegradable polymer/hydroxyapatite composites: surface analysis and initial attachment of human osteoblasts. J Biomed Mater Res 55 (2001) 475-486
7. Calandrelli L., Immirzi B., Malinconico M., Luessenheide S., Passaro I., Pasquale R.D., et al. Natural and synthetic hydroxyapatite filled PCL: mechanical properties and biocompatibility analysis. J Bioact Compat Polym 19 (2004) 301-313
8. Ciapetti G., Ambrosio L., Savarino L., Granchi D., Cenni E., Baldini N., et al. Osteoblast growth and function in porous poly e-caprolactone matrices for bone repair: a preliminary study. Biomaterials 24 (2003) 3815-3824
9. Kim H.-W., Knowles J.C., and Kim H.-E. Hydroxyapatite/poly(e-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials 25 (2004) 1279-1287
10. Yu H., VandeVord P.J., Gong W., Wu B., Song Z., Matthew H.W., et al. Promotion of osteogenesis in tissue-engineered bone by pre-seeding endothelial progenitor cells-derived endothelial cells. J Orthop Res 26 8 (2008) 1147-1152
11. Yu H., Matthew H.W., Wooley P.H., and Yang S.-Y. Effect of porosity and pore size on microstructures and mechanical properties of poly-e-caprolactone-hydroxyapatite composites. J Biomed Mater Res B Appl Biomater (2008) doi:10.1002/jbm.b.31054
12. Yang S.-Y., Yu H., Gong W., Wu B., Mayton L., Costello R., et al. Murine model of prosthesis failure for the long-term study of aseptic loosening. J Orthop Res 25 5 (2007) 603-611
13. Hess D.C., Hill W.D., Martin-Studdard A., Carroll J., Brailer J., and Carothers J. Bone marrow as a source of endothelial cells and NeuN-expressing cells after stroke. Stroke 33 (2002) 1362-1368
14. Kaigler D., Krebsbach P.K., Polverini P.J., and David J.M. Role of vascular endothelial growth factor in bone marrow stromal cells modulation of endothelial cells. Tissue Eng 9 1 (2003) 95-103
15. Krebsbach P.H., Kuznetsov S.A., Bianco P., and Robey P.G. Bone marrow stromal cells: characterization and clinical application. Crit Rev Oral Biol Med 10 (1999) 165-181
16. Midy V., Hollande E., Rey C., Dard M., and Plouët J. Adsorption of vascular endothelial growth factor to two different apatitic materials and its release. J Mater Sci Mater Med 12 4 (2001) 293-298
17. Pezzatini S., Solito R., Morbidelli L., Lamponi S., Boanini E., Bigi A., et al. The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions. J Biomed Mater Res (part A) 76 3 (2006) 656-663
18. Stayton P.S., Drobny G.P., Shaw W.J., Long J.R., and Gilbert M. Molecular recognition at the protein-hydroxyapatite interface. Crit Rev Oral Biol Med 14 5 (2003) 370-376
19. Dong J., Uemura T., Kojima H., Kikuchi M., Tanaka J., and Tateishi T. Application of low-pressure system to sustain in vivo bone formation in osteoblast/porous hydroxyapatite composite. Materials Science and Engineering: C 17 1-2 (2001) 37-43
20. Lloyd-Jones D.M., and Bloch K.D. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med 47 (1996) 365-375
21. Sun J.-S., Tsuang Y.-H., Liao C.-J., Liu H.-C., Hang Y.-S., and Lin F.-H. The effects of calcium phosphate particles on the growth of osteoblasts. J Biomed Mater Res 37 3 (1997) 324-334
22. Kilian O., Fuhrmann R., Alt V., Noll T., Coskun S., Dingeldein E., et al. Plasma transglutaminase factor XIII induces microvessel ingrowth into biodegradable hydroxyapatite implants in rats. Biomaterials 26 14 (2005) 1819-1827
23. Uemura T., Dong J., Wang Y., Kojima H., Saito T., Iejima D., et al. Transplantation of cultured bone cells using combinations of scaffolds and culture techniques. Biomaterials 24 13 (2003) 2277-2286
24. Dennis J.E., and Caplan A.I. Porous ceramic vehicles for rat-marrow-derived (Rattus norvegicus) osteogenic cell delivery: effects of pretreatment with fibronectin and laminin. J Oral Implantol 19 (1993) 106-115
25. Schliephake H., Knebel J.W., Aufderheide M., and Tauscher M. Use of cultivated osteoprogenitor cells to increase bone formation in segmental mandibular defects: an experimental pilot study in sheep. Int J Oral Maxillofac Surg 30 (2001) 531-537
26. Bab I., Passi-Even L., Gazit D., Sekeles E., Ashton B.A., Peylan-Ramu N., et al. Osteogenesis in in vivo diffusion chamber cultures of human marrow cells. Bone Miner 4 (1988) 373-386
27. Cui Q., Ming Xiao Z., Balian G., and Wang G.J. Comparison of lumbar spine fusion using mixed and cloned marrow cells. Spine 26 (2001) 2305-2310
28. Yaszemski M.J., Payne R.G., Hayes W.C., Langer R., and Mikos A.G. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 17 2 (1996) 175-185